A two-site enzyme-linked immunosorbent assay for cytokeratin 8
✍ Scribed by B. Sundström; T. Stigbrand
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 395 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
A monoclonal enzyme-linked immunosorbent assay ELISA) was developed for the determination in biological I luids of cytokeratin 8, a potential marker for malignant diseases. Two monoclonal antibodies (MAbs), TS 3 and T S 4, with different epitope specificity, were selected from 4 cytokeratin-8 reactive antibodies. TS 3 was used for coating and TS 4 as HRP-conjugate, respectively. Antibodies were selected with the aim of optimizing the discriminatory capacity between cytokeratin 8 levels in sera from healthy persons and from patients with malignant diseases. In sera from healthy individuals the mean value was determined to be 3.1 2 2.3 ng/ml with an upper cut-off level of 7.8 ng/ml (+ 2 SD) using purified cytokeratin 8 as standard. Sera from patients with colon cancer and pancreatic cancer were found to have significantly elevated levels, showing a 4to more than 10-fold increase compared with the normal level. In patients with ovarian cancer no significant elevation was seen. Cytokeratin 8 monitoring may be of value for patients with colon and pancreatic cancer.
' O 9 419439 (1980).
📜 SIMILAR VOLUMES
## Abstract Interleukin (IL)‐6 and IL‐8 were measured in 101 serum samples collected from eight intensive‐care unit patients using a polystyrene‐based stick enzyme‐linked immunosorbent assay (STICKELISA) system. This system consisted of an immobilized‐antibody ELISA stick and a noncontact spectroph